@article{42009,
      author = {Cho, Skye},
      url = {http://tind.wipo.int/record/42009},
      title = {The Current Application of the Myriad and Mayo/Alice  Rulings on Patent Eligibility Inconsistent Results and  Contradistinguishing Biotechnology Products},
      abstract = {This  Note attempts to navigate the current patent  eligibility framework and how it has   been   applied   by    different   courts   regarding   patent   claims   of  biotechnology  products.  Part  I  of  this  Note  covers   both  a  brief  and informative scientific overview of DNA,  RNA, and cDNA, and a history of  gene  patents,  including   the  development  of  a  judicial  exception  to patent   ineligibility  using  the  framework  provided  byMyriad   Genetics8and Mayo/Alice.9Part  II  of  this  Note   discusses  four  cases  considering patent  claims  of   biotechnology  products  and  compares  how  the  courts  applied  the Myriad  Genetics and Mayo/Aliceframework  to   their  facts differently.  Lastly,  Part  IIIsets  up  a   hypothetical  patent  claim  using recent   science    technology, Clustered   Regularly   Interspaced   Short  Palindromic  Repeats  (CRISPR), to  apply  the Myriad   Geneticsand Mayo/Aliceframework by referring to the cases  in Part II. Additionally, Part III will provide suggestions  as to what the USPTO can do to clarify the  seemingly   inconsistent  results  of  the  hypothetical  patent  claim  depending on the jurisdiction.},
      recid = {42009},
      pages = {36 pages},
}